Beacon Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History

Beacon Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	SELL	$421.16 - $509.5 $13,055 - $15,794	-31 Reduced 17.13%	150 $66,000
Q1 2025 Apr 21, 2025	BUY	$402.49 - $513.76 $12,477 - $15,926	31 Added 20.67%	181 $87,000
Q3 2024 Nov 07, 2024	BUY	$460.0 - $505.78 $3,220 - $3,540	7 Added 4.9%	150 $69,000
Q1 2024 May 16, 2024	SELL	$407.69 - $446.08 $407 - $446	-1 Reduced 0.69%	143 $59,000
Q4 2023 Jan 09, 2024	BUY	$343.0 - $410.68 $49,049 - $58,727	143 Added 14300.0%	144 $58,000

Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $221 - $260	1 New	1 $0

1,787

231M

1.83M

1.21M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Beacon Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Capital Management, LLC with notifications on news.